# US 2024/0399625 A1 · Hydrogel Microstructure Arrays, Methods of Making and Uses Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0399625 A1
- Document ID: US20240399625A1
- Status: Published application
- Kind: A1
- Application number: 18/696,755
- Filed: 2022-09-29
- Published: 2024-12-05
- Earliest claimed: 2021-09-29
- Assignees: McMaster University
- Applicants: McMaster University
- Inventors: Zeinab Hosseinidoust; Lei Tian
- Web page: https://patentgrep.com/patent/US20240399625A1

## CPC

- B01J 13/0052: {Preparation of gels}
- B29C 33/424: {Moulding surfaces provided with means for marking or patterning (for injection moulding B29C45/372)}
- A61L 26/0047: {Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042}
- A61L 26/0057: {Ingredients of undetermined constitution or reaction products thereof}
- A61L 26/0066: {Medicaments; Biocides}
- A61L 26/008: {Hydrogels or hydrocolloids}
- A61L 27/34: Macromolecular materials
- A61L 27/3637: {characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae}
- A61L 27/3687: {characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents}
- A61L 27/3691: {characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation}
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- B01J 13/0091: {Preparation of aerogels, e.g. xerogels}
- B29C 33/3842: {Manufacturing moulds, e.g. shaping the mould surface by machining}
- B29C 33/40: Plastics, e.g. foam or rubber
- B29C 41/003: {characterised by the choice of material}
- B29C 41/02: for making articles of definite length, i.e. discrete articles
- B29C 41/38: Moulds, cores or other substrates
- B29C 41/42: Removing articles from moulds, cores or other substrates {(B29C33/444 and B29C37/0017 take precedence)}
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- B29K 2089/00: Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material
- B29K 2105/0035: {Medical or pharmaceutical agents}
- B29K 2105/0061: {Gel or sol}
- B29K 2105/24: crosslinked or vulcanised
- B29K 2825/06: PS, i.e. polystyrene
- B29K 2995/006: Bio-degradable, e.g. bioabsorbable, bioresorbable or bioerodible
- B29K 2995/0092: hydrophilic
- B29L 2031/753: {Medical equipment; Accessories therefor (bloodbags, medical bags B29L2031/7148; artificial eyes B29L2011/0008)}
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29L: INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES

## Abstract

This disclosure relates to a hydrogel comprising a crosslinked biomolecule, wherein the hydrogel comprises microscale structures. Also described is a hydrogel comprising an ordered array of semi-spherical microbumps, wherein the hydrogel is bacteria-repellent. Also described is a hierarchically-structured protein hydrogel that inhibits long term attachment of multidrug resistant Staphylococcus aureus up to 100× over a flat hydrogel. Methods of making and uses thereof are also disclosed herein.

## Claims

### Claim 1

A hydrogel comprising a crosslinked biomolecule, wherein the hydrogel comprises microscale structures.

### Claim 2 (depends on 1)

The hydrogel of claim 1, wherein the microscale structures comprise rounded projections.

### Claim 3 (depends on 1)

The hydrogel of claim 1, wherein the microscale structures comprise spheres, semi-spheres, and/or shallow-arcuate projections.

### Claim 4 (depends on 1)

The hydrogel of claim 1, wherein the microscale structures form ordered arrays on a surface of the hydrogel.

### Claim 5 (depends on 1)

The hydrogel of claim 1, wherein the biomolecule is crosslinked with one or more crosslinkers comprising chemical and/or physical crosslinkers.

### Claim 6 (depends on 5)

The hydrogel of claim 5, wherein the one or more crosslinkers comprises glutaraldehyde, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide, sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate or gold nanoparticles.

### Claim 7 (depends on 5)

The hydrogel of claim 5, wherein the one or more crosslinkers comprises glutaraldehyde.

### Claim 8 (depends on 1)

The hydrogel of claim 1, further comprising nanoscale features.

### Claim 9 (depends on 8)

The hydrogel of claim 8, wherein the microscale structures and nanoscale features form hierarchical structures.

### Claim 10 (depends on 1)

The hydrogel of claim 1, further comprising a heat-sensitive molecule, such as a biological agent.

### Claim 11 (depends on 1)

The hydrogel of claim 1, wherein the biomolecule is a protein.

### Claim 12 (depends on 11)

The hydrogel of claim 11, wherein the protein is an albumin.

### Claim 13 (depends on 12)

The hydrogel of claim 12, wherein the albumin is bovine serum albumin.

### Claim 14 (depends on 1)

The hydrogel of claim 1, wherein the microscale structures have an aspect ratio of from about 0.05 to about 0.90.

### Claim 15 (depends on 1)

The hydrogel of claim 1, having a contact angle of from about 10° to about 80°.

### Claim 16 (depends on 1)

The hydrogel of claim 1, wherein the hydrogel exhibits hydrophilic properties.

### Claim 17 (depends on 1)

The hydrogel of claim 1, wherein the hydrogel exhibits repellency to bacteria.

### Claim 18 (depends on 1)

The hydrogel of claim 1, wherein the hydrogel is biodegradable.

### Claim 19 (depends on 1)

The hydrogel of claim 1, further comprising additives.

### Claim 20 (depends on 19)

The hydrogel of claim 19, wherein the additives comprise bacteriophages, antibiotics, proteins, peptides, amino acids, carbohydrates, lipids, and/or nucleic acids.

### Claim 21 (depends on 19)

The hydrogel of claim 19, wherein the bacteriophages self-assemble into bundles.

### Claim 22 (depends on 19)

The hydrogel of claim 19, wherein the bacteriophages comprise filamentous bacteriophages.

### Claim 23 (depends on 19)

The hydrogel composition of claim 19, wherein the bacteriophages comprise Escherichia coli bacteriophages, such as f1, M13, or fd bacteriophages, or combinations thereof.

### Claim 24 (depends on 1)

The hydrogel of claim 1, wherein the hydrogel does not kill bacteria.

### Claim 25 (depends on 1)

The hydrogel of claim 1, wherein the hydrogel inhibits long term attachment of multidrug resistant Staphylococcus aureus up to 100× over a flat hydrogel.

### Claim 26 (depends on 1)

A device or article comprising the hydrogel of claim 1.

### Claim 27 (depends on 26)

The device of claim 26, wherein the hydrogel is on the surface of the device or article.

### Claim 28 (depends on 1)

A biosensor substrate comprising the hydrogel of claim 1.

### Claim 29

A method for making a hydrogel with microscale structures, the method comprising:
a) mixing a molecule, optionally a biomolecule, with a crosslinker;
b) depositing at least one layer of the molecule with the crosslinker on an optionally activated surface layer of a mold comprising micropores;
c) allowing the molecule with a crosslinker to form a hydrogel;
d) removing the hydrogel from the mold.

### Claim 30 (depends on 29)

The method of claim 29, wherein the hydrogel is optionally formed under vacuum.

### Claim 31 (depends on 29)

The method of claim 29, wherein activating the surface layer of the mold comprises tuning the hydrophilicity of the surface layer of the mold.

### Claim 32 (depends on 29)

The method of claim 29, wherein the micropores are in a honeycomb formation.

### Claim 33 (depends on 29)

The method of claim 29, wherein the microscale structures comprise rounded projections.

### Claim 34 (depends on 29)

The method of claim 29, wherein the microscale structures comprise spheres, semi-spheres, and/or shallow-arcuate projections of varied sphericity.

### Claim 35 (depends on 29)

The method of claim 29, wherein the microscale structures form ordered arrays on a surface of the hydrogel.

### Claim 36 (depends on 29)

The method of claim 29, wherein sphericity of the microscale structures is tunable.

### Claim 37 (depends on 36)

The method of claim 36, whereby optionally activating a surface layer of the mold and/or optionally forming the hydrogel under vacuum changes the sphericity of the microscale structures.

### Claim 38 (depends on 29)

The method of claim 29, further comprising depositing a nanogel layer on the surface of the mold before depositing at least one layer of the molecule with the crosslinker on the optionally activated surface layer of the mold.

### Claim 39 (depends on 38)

The method of claim 38, wherein the nanogel layer forms nanoscale features.

### Claim 40 (depends on 39)

The method of claim 39, wherein the microscale structures and nanoscale features form hierarchical structures.

### Claim 41 (depends on 40)

The method of claim 40, wherein roughness of the hierarchical structures is tunable.

### Claim 42 (depends on 41)

The method of claim 41, whereby optionally activating the surface layer of the mold and/or optionally performing forming the hydrogel under vacuum changes the roughness of the hierarchical structures.

### Claim 43 (depends on 29)

The method of claim 29, wherein the mold is fabricated by a breath figure method.

### Claim 44 (depends on 29)

The method of claim 29, wherein the mold comprises a thermoplastic polymer.

### Claim 45 (depends on 29)

The method of claim 29, wherein the mold comprises polystyrene.

### Claim 46 (depends on 29)

The method of claim 29, wherein activating the mold comprises introducing oxygen-rich polar functional groups, in, on or over the substrate.

### Claim 47 (depends on 29)

The method of claim 29, wherein activating the mold comprises plasma treatment.

### Claim 48 (depends on 29)

The method of claim 29, wherein the biomolecule comprises any molecule comprising carbon atoms.

### Claim 49 (depends on 29)

The method of claim 29, wherein the biomolecule comprises a protein, peptide, amino acid, carbohydrate, lipid, and/or nucleic acid.

### Claim 50 (depends on 48)

The method of claim 48, wherein the protein comprises an albumin, optionally at from about 1% to about 10%.

### Claim 51 (depends on 29)

The method of claim 29, wherein the crosslinker comprises glutaraldehyde, optionally at from about 0.1% to about 5%.

### Claim 52 (depends on 29)

The method of claim 29, wherein forming the hydrogel comprises incubating the biomolecule with a crosslinker on the surface of the mold for a period of time, such as from about 10 minutes to about 1 hour, such as about 30 minutes, at a temperature of from about 4° C. to about 37° C., such as about room temperature.

### Claim 53 (depends on 29)

A hydrogel made by the method of claim 29.

### Claim 54

A hydrogel comprising an ordered array of semi-spherical microbumps, wherein the hydrogel is bacteria-repellent.

### Claim 55 (depends on 53)

The hydrogel of claim 53, wherein the hydrogel does not kill the bacteria.

### Claim 56

A hierarchically-structured protein hydrogel that inhibits long term attachment of multidrug resistant Staphylococcus aureus up to 100× over a flat hydrogel.

### Claim 57

A breath figure templating method for creating hydrogels with hierarchically ordered, isotropic, nano-on-micro structures, wherein the method allows for tunable sphericity and roughness of the structures using a single template.

### Claim 58 (depends on 56)

The method of claim 56, wherein the sphericity of the structures is controlled by changing plasma coating of the template and using vacuum on the template during a crosslinking reaction.
